Symbols / UTRS $0.00 +0.00% Minerva Surgical, Inc.

Healthcare • Medical Devices • United States • PNK
UTRS Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Darin Hammers
Exch · Country PNK · United States
Market Cap 887.00
Enterprise Value 32.43M
Income -33.45M
Sales 51.69M
FCF (ttm) -18.49M
Book/sh 2.28
Cash/sh 1.25
Employees 174
Insider 10d —
IPO Oct 22, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -0.00
PEG —
P/S 0.00
P/B 0.00
P/C —
EV/EBITDA -1.27
EV/Sales 0.63
Quick Ratio 0.88
Current Ratio 1.88
Debt/Eq 215.01
LT Debt/Eq —
EPS (ttm) -0.76
EPS next Y -2.89
EPS Growth —
Revenue Growth -4.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2023-11-13
Earnings (prior) 2023-11-13
ROA -27.35%
ROE -160.07%
ROIC —
Gross Margin 54.18%
Oper. Margin -50.95%
Profit Margin -64.71%
Shs Outstand 8.88M
Shs Float 2.77M
Insider Own 0.00%
Instit Own 0.00%
Short Float 3.70%
Short Ratio 0.51
Short Interest 37.42K
52W High 0.00
vs 52W High -90.00%
52W Low 0.00
vs 52W Low 900.00%
Beta 154.71
Impl. Vol. —
Rel Volume 15.62
Avg Volume 32.00
Volume 500.00
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $0.00
Price $0.00
Change 0.00%
About

Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States. The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities. It also offers Resectr, a tissue resection device to diagnose and treat polyps; and HERizon electronic disposable hysteroscope, image processor, Hysto-Kit, and endoscopic accessories that helps gynecologists to evaluate abnormal uterine bleeding and provide care. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-37.48
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
News
RSS: Latest UTRS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2022-12-31 2021-12-31
Total Revenue
50.29
-3.47%
52.10
Operating Revenue
50.29
-3.47%
52.10
Cost Of Revenue
23.05
+6.82%
21.58
Reconciled Cost Of Revenue
23.05
+6.82%
21.58
Gross Profit
27.24
-10.75%
30.52
Operating Expense
58.14
-2.56%
59.67
Research And Development
5.44
+2.85%
5.29
Selling General And Administration
52.70
-3.09%
54.38
Selling And Marketing Expense
38.33
+19.06%
32.19
General And Administrative Expense
14.37
-35.22%
22.18
Other Gand A
14.37
-35.22%
22.18
Total Expenses
81.19
-0.07%
81.25
Operating Income
-30.90
-6.02%
-29.14
Total Operating Income As Reported
-30.90
-6.02%
-29.14
EBITDA
-20.07
-2347.82%
0.89
Normalized EBITDA
-20.07
-6.46%
-18.86
Reconciled Depreciation
10.81
+1.75%
10.62
EBIT
-30.88
-217.46%
-9.73
Total Unusual Items
0.00
-100.00%
19.75
Total Unusual Items Excluding Goodwill
0.00
-100.00%
19.75
Special Income Charges
0.00
+100.00%
-18.26
Other Special Charges
—
18.26
Restructuring And Mergern Acquisition
—
0.00
Net Income
-34.11
-58.93%
-21.46
Pretax Income
-34.10
-58.94%
-21.45
Net Non Operating Interest Income Expense
-3.13
+73.26%
-11.72
Interest Expense Non Operating
3.22
-72.53%
11.73
Net Interest Income
-3.13
+73.26%
-11.72
Interest Expense
3.22
-72.53%
11.73
Interest Income Non Operating
0.09
+790.00%
0.01
Interest Income
0.09
+790.00%
0.01
Other Income Expense
-0.07
-100.36%
19.41
Other Non Operating Income Expenses
-0.07
+79.71%
-0.34
Gain On Sale Of Security
—
38.01
Tax Provision
0.01
+22.22%
0.01
Tax Rate For Calcs
0.00
-22.22%
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
5.33
Net Income Including Noncontrolling Interests
-34.11
-58.93%
-21.46
Net Income From Continuing Operation Net Minority Interest
-34.11
-58.93%
-21.46
Net Income From Continuing And Discontinued Operation
-34.11
-58.93%
-21.46
Net Income Continuous Operations
-34.11
-58.93%
-21.46
Normalized Income
-34.11
+4.93%
-35.88
Net Income Common Stockholders
-34.11
-58.93%
-21.46
Diluted EPS
-23.60
+61.44%
-61.20
Basic EPS
-23.60
+61.44%
-61.20
Basic Average Shares
1.44
+310.83%
0.35
Diluted Average Shares
1.44
+310.83%
0.35
Diluted NI Availto Com Stockholders
-34.11
-58.93%
-21.46
Gain On Sale Of PPE
—
3.04
Line Item Trend 2022-12-31 2021-12-31
Total Assets
68.90
-40.13%
115.09
Current Assets
36.12
-51.84%
75.00
Cash Cash Equivalents And Short Term Investments
6.94
-82.90%
40.61
Cash And Cash Equivalents
6.94
-82.90%
40.61
Cash Equivalents
3.15
-91.83%
38.52
Cash Financial
3.79
+81.83%
2.09
Receivables
7.24
-0.66%
7.29
Accounts Receivable
7.24
-0.66%
7.29
Gross Accounts Receivable
7.94
+1.95%
7.79
Allowance For Doubtful Accounts Receivable
-0.70
-40.00%
-0.50
Inventory
16.85
+7.45%
15.68
Raw Materials
9.71
+56.91%
6.19
Finished Goods
7.14
-24.78%
9.49
Prepaid Assets
3.72
-6.67%
3.99
Restricted Cash
0.60
-91.71%
7.28
Other Current Assets
0.76
+406.71%
0.15
Total Non Current Assets
32.78
-18.23%
40.09
Net PPE
5.31
+15.63%
4.59
Gross PPE
15.74
+13.13%
13.91
Accumulated Depreciation
-10.43
-11.89%
-9.32
Properties
0.00
0.00
Machinery Furniture Equipment
1.05
-40.56%
1.77
Construction In Progress
0.13
-69.39%
0.43
Other Properties
14.40
+24.61%
11.55
Leases
0.15
+0.00%
0.15
Goodwill And Other Intangible Assets
26.78
-23.43%
34.97
Other Intangible Assets
26.78
-23.43%
34.97
Other Non Current Assets
0.69
+31.87%
0.52
Total Liabilities Net Minority Interest
51.72
-27.14%
70.99
Current Liabilities
14.28
-37.40%
22.81
Payables And Accrued Expenses
7.99
-42.14%
13.81
Payables
3.08
-28.25%
4.29
Accounts Payable
2.80
-22.73%
3.63
Current Accrued Expenses
4.91
-48.39%
9.52
Pensionand Other Post Retirement Benefit Plans Current
3.70
+5.20%
3.52
Total Tax Payable
0.27
-58.75%
0.66
Current Debt And Capital Lease Obligation
2.25
+1089.95%
0.19
Current Debt
1.89
+902.12%
0.19
Other Current Borrowings
1.89
+902.12%
0.19
Current Capital Lease Obligation
0.35
0.00
Current Deferred Liabilities
0.34
-29.81%
0.48
Current Deferred Revenue
0.34
+64.56%
0.21
Other Current Liabilities
—
5.00
Total Non Current Liabilities Net Minority Interest
37.44
-22.29%
48.18
Long Term Debt And Capital Lease Obligation
37.44
-4.21%
39.09
Long Term Debt
37.44
-4.21%
39.09
Other Non Current Liabilities
—
9.09
Preferred Securities Outside Stock Equity
—
0.00
Stockholders Equity
17.18
-61.04%
44.10
Common Stock Equity
17.18
-61.04%
44.10
Capital Stock
0.03
+3.57%
0.03
Common Stock
0.03
+3.57%
0.03
Preferred Stock
0.00
0.00
Share Issued
1.49
+3.45%
1.44
Ordinary Shares Number
1.49
+3.45%
1.44
Additional Paid In Capital
300.81
+2.45%
293.62
Retained Earnings
-283.67
-13.67%
-249.56
Gains Losses Not Affecting Retained Earnings
0.01
+0.00%
0.01
Other Equity Adjustments
0.01
+0.00%
0.01
Total Equity Gross Minority Interest
17.18
-61.04%
44.10
Total Capitalization
54.62
-34.34%
83.19
Working Capital
21.84
-58.15%
52.20
Invested Capital
56.52
-32.06%
83.19
Total Debt
39.69
+1.55%
39.09
Net Debt
32.39
—
Capital Lease Obligations
0.35
0.00
Net Tangible Assets
-9.60
-205.07%
9.13
Tangible Book Value
-9.60
-205.07%
9.13
Derivative Product Liabilities
—
0.00
Interest Payable
0.32
+69.84%
0.19
Line Item Trend 2022-12-31 2021-12-31
Operating Cash Flow
-35.57
-58.93%
-22.38
Cash Flow From Continuing Operating Activities
-35.57
-58.93%
-22.38
Net Income From Continuing Operations
-34.11
-58.93%
-21.46
Depreciation Amortization Depletion
10.81
+1.75%
10.62
Depreciation And Amortization
10.81
+1.75%
10.62
Other Non Cash Items
-8.22
-185.47%
9.62
Stock Based Compensation
6.98
+2.36%
6.82
Asset Impairment Charge
0.03
0.00
Deferred Tax
—
0.00
Deferred Income Tax
—
0.00
Operating Gains Losses
—
-19.42
Gain Loss On Investment Securities
—
-37.68
Change In Working Capital
-11.05
-29.29%
-8.55
Change In Receivables
0.05
-95.58%
1.09
Changes In Account Receivables
0.05
-95.58%
1.09
Change In Inventory
-4.13
+54.42%
-9.07
Change In Prepaid Assets
-0.34
+93.23%
-5.03
Change In Payables And Accrued Expense
-5.57
-245.28%
3.83
Change In Accrued Expense
-4.69
-980.83%
0.53
Change In Payable
-0.88
-126.70%
3.30
Change In Account Payable
-0.88
-126.70%
3.30
Change In Other Working Capital
0.18
-70.91%
0.63
Change In Other Current Assets
-0.43
0.00
Change In Other Current Liabilities
-0.82
0.00
Investing Cash Flow
-0.07
+87.50%
-0.58
Cash Flow From Continuing Investing Activities
-0.07
+87.50%
-0.58
Net PPE Purchase And Sale
-0.07
+87.50%
-0.58
Purchase Of PPE
-0.07
+87.50%
-0.58
Capital Expenditure
-0.07
+87.50%
-0.58
Net Business Purchase And Sale
—
0.00
Purchase Of Business
—
0.00
Financing Cash Flow
-4.96
-110.74%
46.21
Cash Flow From Continuing Financing Activities
-4.96
-110.74%
46.21
Net Issuance Payments Of Debt
0.00
-100.00%
4.16
Issuance Of Debt
0.00
-100.00%
39.53
Repayment Of Debt
0.00
+100.00%
-35.38
Long Term Debt Issuance
0.00
-100.00%
39.53
Long Term Debt Payments
0.00
+100.00%
-35.38
Net Long Term Debt Issuance
0.00
-100.00%
4.16
Net Common Stock Issuance
0.04
-99.95%
70.72
Net Other Financing Charges
-5.00
+82.56%
-28.67
Changes In Cash
-40.60
-274.65%
23.25
Beginning Cash Position
48.41
+92.38%
25.17
End Cash Position
7.81
-83.87%
48.41
Free Cash Flow
-35.64
-55.21%
-22.96
Interest Paid Supplemental Data
2.81
+21.14%
2.32
Income Tax Paid Supplemental Data
0.01
-38.89%
0.02
Common Stock Issuance
0.04
-99.95%
70.72
Issuance Of Capital Stock
0.04
-99.95%
70.72
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category